Skip to main content

Vivoryon Therapeutics N.V. Reports Q3 2025 Financial Results and Business Updates

Vivoryon Therapeutics N.V. Reports Q3 2025 Financial Results and Business UpdatesNew analysis of data from varoglutamstat Phase 2 program for patients with lower baseline eGFR shows consistent and pronounced treatment effect, further supporting plans to advance development in stage 3b/4 DKD Compelling kidney function data from VIVIAD Phase 2b study presented in late-breaking poster session at ASN kidney week, the world’s premier nephrology meetingSuccessful completion of private placement supported by existing and new shareholders raising EUR 5.1 million; extends cash runway well into Q3 2026, providing financial runway and flexibility to realize strategic partnership Management to host conference call today at 3:00 pm CET (9:00 am EST)Halle (Saale) / Munich, Germany, December 4, 2025 – Vivoryon Therapeutics N.V. (Euronext...

Continue reading

Descartes Announces Fiscal 2026 Third Quarter Financial Results

Record Revenues and Income from Operations; Application Filed to Commence Normal Course Issuer Bid; CFO Transition Plan Outlined for Next Fiscal Year WATERLOO, Ontario and ATLANTA, Dec. 03, 2025 (GLOBE NEWSWIRE) — The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results for its fiscal 2026 third quarter (Q3FY26). All financial results referenced are in United States (US) currency and, unless otherwise indicated, are determined in accordance with US Generally Accepted Accounting Principles (GAAP). “Our business performed ahead of our plans in Q3FY26, as we continue to add more solutions and content to our Global Logistics Network,” said Edward J. Ryan, Descartes’ CEO. “Our customers have faced continued tariff volatility, and heightened levels of changes to sanctioned and restricted...

Continue reading

Methode Electronics, Inc. Reports Fiscal 2026 Second Quarter Financial Results

Net sales of $246.9 million down 15.6% year-over-year; up 2.6% on a sequential quarter basis Net loss of $9.9 million or 4.0% of net sales; adjusted EBITDA margin of 7.1% Reaffirming fiscal 2026 guidance for net sales of $900 million to $1 billion and adjusted EBITDA of $70 to $80 millionCHICAGO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, lighting, and power distribution applications, today announced financial results for the second quarter of fiscal 2026 ended November 1, 2025. President and Chief Executive Officer Jon DeGaynor said, “Methode’s transformation journey made further progress in the quarter and is on track. I am proud of the unwavering commitment and hard work that the Methode team has put into our transformation....

Continue reading

Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update

–  Fourth quarter fiscal 2025 revenue up 5.9% to $138.1 million–  Fiscal 2025 revenue increased 4.5% to $513.0 million–  Fourth quarter fiscal 2025 operating loss decreased 48.5% to $6.8 million–  Fiscal 2025 operating loss decreased 64.2% to $30.9 million–  Conference call scheduled for today at 4:30 pm ET WEST LAFAYETTE, Ind., Dec. 03, 2025 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (“Q4 FY 2025”) ended September 30, 2025, and twelve months (“FY 2025”) ended September 30, 2025. Revenue by Segment (in millions of USD)    Three Months EndedSeptember 30,   %change...

Continue reading

nCino Reports Third Quarter Fiscal Year 2026 Financial Results

Total Revenues of $152.2M, up 10% year-over-year Subscription Revenues of $133.4M, up 11% year-over-year GAAP Operating Margin of 8%, up over 800 basis points year-over-year Non-GAAP Operating Margin of 26%, up 600 basis points year-over-yearWILMINGTON, N.C., Dec. 03, 2025 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced financial results for the third quarter of fiscal year 2026, ended October 31, 2025. “I’m extremely proud of our team’s strong execution in the third quarter, delivering results that exceeded expectations while advancing our AI leadership position,” said Sean Desmond, CEO at nCino. “The momentum we’re seeing across customer segments, geographies, and products reinforces our conviction in...

Continue reading

Five Below, Inc. Announces Third Quarter Fiscal 2025 Financial Results

Q3 Net Sales Increase of 23.1% to $1.0 Billion; Comparable Sales Increase of 14.3% Q3 GAAP Diluted EPS of $0.66, Q3 Adjusted Diluted EPS of $0.68 Increases Full Year 2025 Sales and EPS Outlook PHILADELPHIA, PA, Dec. 03, 2025 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE) today announced financial results for the third quarter and year to date period ended November 1, 2025. For the third quarter ended November 1, 2025:Net sales increased by 23.1% to $1,038.3 million from $843.7 million in the third quarter of fiscal 2024; comparable sales increased by 14.3%. The Company opened 49 net new stores and ended the quarter with 1,907 stores in 44 states. This represents an increase in stores of 9.0% from the end of the third quarter of fiscal 2024. Operating income was $43.3 million compared to an operating loss of $0.6 million in...

Continue reading

HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results

Highlights of the third quarter include:Revenue increased 7% to $322.2 million. Net income per diluted share rose to $0.59 from $0.06 one year ago, and non-GAAP net income per diluted share increased 29% to $1.01. Total HSA Assets grew 15% to $34.4 billion. Returned $93.7 million to shareholders through stock repurchases. Further reduced HSA cash repricing risk with a cumulative $2.25 billion 5-year Treasury bond hedge at 3.94%.DRAPER, Utah, Dec. 03, 2025 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), a leader in administering health savings accounts (“HSAs”) and complementary consumer-directed benefits (“CDBs”), today announced financial results for its third quarter ended October 31, 2025. “HealthEquity delivered a record third quarter for fiscal 2026,...

Continue reading

SSCP Lager BidCo AB (publ) – Correction of interim report for third quarter 2025

SSCP Lager BidCo AB (publ) – Correction of interim report for period 1 July – 30 September 2025. On 28 November 2025, SSCP Lager BidCo AB (publ) published its interim report for the third quarter of 2025, in which errors have been identified following publication. Today SSCP Lager BidCo AB (publ) has published an updated and corrected version of the interim report due to the reasons set out below. The updated and corrected report can be downloaded on www.logent.se or via the link below. No updates and corrections have been made other than those described below.Condensed consolidated statement of cash flows on page 17 has been corrected due to that the consolidation of HUB logistics group was not correctly made, affecting both Q3 2025 and Jan-Sep 2025 columns. References to cash flow on page 2 and page 8 were also corrected accordingly.For...

Continue reading

Castor Maritime Inc. Reports Net Income of $21.0 Million for the Three Months Ended September 30, 2025 and Net Income of $4.0 Million for the Nine Months Ended September 30, 2025

LIMASSOL, Cyprus, Dec. 03, 2025 (GLOBE NEWSWIRE) — Castor Maritime Inc. (NASDAQ: CTRM) (“Castor” or the “Company”), a diversified global shipping and energy company, today announced its results for the three months and nine months ended September 30, 2025. Highlights of the Third Quarter Ended September 30, 2025:Total vessel revenues: $11.4 million for the three months ended September 30, 2025, as compared to $13.4 million for the three months ended September 30, 2024, or a 14.9% decrease; Revenue from services: $9.5 million for the three months ended September 30, 2025; Net income of $21.0 million for the three months ended September 30, 2025, as compared to $2.8 million for the three months ended September 30, 2024, or a 650.0% increase; Adjusted net income(1) of $2.4 million for the three months ended September 30, 2025, as...

Continue reading

Yuanbao Inc. Announces Third Quarter 2025 Unaudited Financial Results

BEIJING, Dec. 03, 2025 (GLOBE NEWSWIRE) — Yuanbao Inc. (“Yuanbao” or the “Company”) (NASDAQ: YB), a leading technology-driven online insurance distributor in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial and Operational HighlightsTotal revenues in the third quarter of 2025 were RMB1,157.9 million (US$162.6 million), representing a 33.6% year-over-year increase from RMB866.8 million in the same period of 2024. Net income in the third quarter of 2025 was RMB370.4 million (US$52.0 million), representing a 51.3% year-over-year increase from RMB244.8 million in the same period of 2024. Net income margin in the third quarter of 2025 was 32.0%, compared with 28.2% in the same period of 2024. Net operating cash inflow in the third quarter of 2025 was...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.